Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol in liver cancer surgery
NCT02261844Phase 2Withdrawn
- Sponsor
- University of Louisville
- Start
- Dec 2015
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in liver cancer, sponsored by University of Louisville. Primary endpoint: Metabolic profile of liver cells at 36 months. Planned start Dec 2015; status: withdrawn.
02
Conditions
liver cancer
Beyond the preview
Go deeper on NCT02261844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02261844.